AR018869A1 - PHARMACEUTICAL COMPOSITION, ITS USE FOR THE PREPARATION OF MEDICINES AND CASE THAT CONTAINS IT - Google Patents
PHARMACEUTICAL COMPOSITION, ITS USE FOR THE PREPARATION OF MEDICINES AND CASE THAT CONTAINS ITInfo
- Publication number
- AR018869A1 AR018869A1 ARP990102848A ARP990102848A AR018869A1 AR 018869 A1 AR018869 A1 AR 018869A1 AR P990102848 A ARP990102848 A AR P990102848A AR P990102848 A ARP990102848 A AR P990102848A AR 018869 A1 AR018869 A1 AR 018869A1
- Authority
- AR
- Argentina
- Prior art keywords
- compositions
- medicines
- preparation
- case
- pharmaceutical composition
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 3
- 150000003839 salts Chemical class 0.000 abstract 2
- 208000001132 Osteoporosis Diseases 0.000 abstract 1
- 208000001164 Osteoporotic Fractures Diseases 0.000 abstract 1
- 210000000988 bone and bone Anatomy 0.000 abstract 1
- KVLLHLWBPNCVNR-SKCUWOTOSA-N capromorelin Chemical compound C([C@@]12CN(CCC1=NN(C2=O)C)C(=O)[C@@H](COCC=1C=CC=CC=1)NC(=O)C(C)(C)N)C1=CC=CC=C1 KVLLHLWBPNCVNR-SKCUWOTOSA-N 0.000 abstract 1
- GXESHMAMLJKROZ-IAPPQJPRSA-N lasofoxifene Chemical compound C1([C@@H]2[C@@H](C3=CC=C(C=C3CC2)O)C=2C=CC(OCCN3CCCC3)=CC=2)=CC=CC=C1 GXESHMAMLJKROZ-IAPPQJPRSA-N 0.000 abstract 1
- 210000003205 muscle Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Physical Education & Sports Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Se describen composiciones farmacéuticas de combinacion y procedimientos que contienen (-)-cis-6-fenil-5-(4-(2-pirrolidin-1-il-etoxi)fenil)-5,6.7,8-tetrahidronaftalen-2-ol o una de sus sales farmacéuticamente aceptables y 2-amino-N-(2-(3a(R)-bencil-2-metil-3-oxo-2,3,3a,4,6,7-hexahidro-pirazolo[4,3-c]piridin-5-il)-1(R)-benciloximetil-2-oxo-etil)-isobutiramida o una de sus sales farmacéuticamente aceptables, a procedimientos para usar tales composiciones ya estuches que contienen tales composiciones. Las composiciones son de utilidad para tratar fragilidad musculoesquelética, incluyendo osteoporosis, fracturaosteoporotica, masa osea reducida, fragilidad y masa muscular reducida.Combination pharmaceutical compositions and processes containing (-) - cis-6-phenyl-5- (4- (2-pyrrolidin-1-yl-ethoxy) phenyl) -5,6,7,8-tetrahydronaphthalen-2-ol are described or one of its pharmaceutically acceptable salts and 2-amino-N- (2- (3a (R) -benzyl-2-methyl-3-oxo-2,3,3a, 4,6,7-hexahydro-pyrazolo [4 , 3-c] pyridin-5-yl) -1 (R) -benzyloxymethyl-2-oxo-ethyl) -isobutyramide or a pharmaceutically acceptable salt thereof, to methods for using such compositions and to cases containing such compositions. The compositions are useful for treating musculoskeletal fragility, including osteoporosis, osteoporotic fracture, reduced bone mass, fragility and reduced muscle mass.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8946998P | 1998-06-16 | 1998-06-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR018869A1 true AR018869A1 (en) | 2001-12-12 |
Family
ID=22217825
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP990102848A AR018869A1 (en) | 1998-06-16 | 1999-06-15 | PHARMACEUTICAL COMPOSITION, ITS USE FOR THE PREPARATION OF MEDICINES AND CASE THAT CONTAINS IT |
Country Status (30)
| Country | Link |
|---|---|
| EP (1) | EP1087764A1 (en) |
| JP (1) | JP2002518326A (en) |
| KR (1) | KR20010052852A (en) |
| CN (1) | CN1301160A (en) |
| AP (1) | AP9901582A0 (en) |
| AR (1) | AR018869A1 (en) |
| AU (1) | AU4054799A (en) |
| BG (1) | BG105041A (en) |
| BR (1) | BR9911324A (en) |
| CA (1) | CA2335134A1 (en) |
| CO (1) | CO5070587A1 (en) |
| EA (1) | EA200001186A1 (en) |
| GT (1) | GT199900087A (en) |
| HN (1) | HN1999000097A (en) |
| HR (1) | HRP20000859A2 (en) |
| HU (1) | HUP0102505A3 (en) |
| ID (1) | ID27599A (en) |
| IL (1) | IL138630A0 (en) |
| IS (1) | IS5691A (en) |
| MA (1) | MA26652A1 (en) |
| NO (1) | NO20006312L (en) |
| OA (1) | OA11505A (en) |
| PA (1) | PA8475901A1 (en) |
| PE (1) | PE20000646A1 (en) |
| PL (1) | PL344981A1 (en) |
| SK (1) | SK18912000A3 (en) |
| TN (1) | TNSN99124A1 (en) |
| TR (1) | TR200003544T2 (en) |
| WO (1) | WO1999065486A1 (en) |
| ZA (1) | ZA993975B (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2653300A (en) * | 1999-02-08 | 2000-08-29 | Mcgill University | Non-human transgenic animal whose germ cells and somatic cells contain a knockout mutation in dna encoding orphan nuclear receptor erralpha |
| EP1156120B1 (en) | 2000-05-08 | 2006-11-22 | Pfizer Products Inc. | Enzymatic resolution of selective estrogen receptor modulators |
| IL145106A0 (en) * | 2000-08-30 | 2002-06-30 | Pfizer Prod Inc | Intermittent administration of a geowth hormone secretagogue |
| CA2420535A1 (en) * | 2000-08-30 | 2002-03-07 | Mary Tanya Am Ende | Sustained release formulations for growth hormone secretagogues |
| US7476653B2 (en) | 2003-06-18 | 2009-01-13 | Tranzyme Pharma, Inc. | Macrocyclic modulators of the ghrelin receptor |
| WO2006024931A2 (en) * | 2004-08-31 | 2006-03-09 | Pfizer Products Inc. | Therapeutic combinations comprising a selective estrogen receptor modulator and a selective androgen receptor modulator |
| CU23558A1 (en) | 2006-02-28 | 2010-07-20 | Ct Ingenieria Genetica Biotech | COMPOUNDS ANALOG TO THE PEPTIDIC SECRETAGOGS OF THE GROWTH HORMONE |
| ES2602789T3 (en) | 2007-02-09 | 2017-02-22 | Ocera Therapeutics, Inc. | Connector intermediates for the synthesis of macrocyclic modulators of the ghrelin receptor |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA51676C2 (en) * | 1995-11-02 | 2002-12-16 | Пфайзер Інк. | (-)cis-6(S)-phenyl-5(R)-[4-(2-pyrrolidin-I-ylethoxy)phenyl]-5,6,7,8-tetrahydronaphthalen-2-ol D-tartrate, a method of its preparation, method of THE treatment OF diseases medicated by agonists of estrogen and a pharmaceutical composition |
| TW432073B (en) * | 1995-12-28 | 2001-05-01 | Pfizer | Pyrazolopyridine compounds |
| HN1996000101A (en) * | 1996-02-28 | 1997-06-26 | Inc Pfizer | COMBINED THERAPY FOR OSTEOPOROSIS |
-
1999
- 1999-06-15 PE PE1999000528A patent/PE20000646A1/en not_active Application Discontinuation
- 1999-06-15 HN HN1999000097A patent/HN1999000097A/en unknown
- 1999-06-15 AP APAP/P/1999/001582A patent/AP9901582A0/en unknown
- 1999-06-15 PA PA19998475901A patent/PA8475901A1/en unknown
- 1999-06-15 ZA ZA9903975A patent/ZA993975B/en unknown
- 1999-06-15 AR ARP990102848A patent/AR018869A1/en not_active Application Discontinuation
- 1999-06-16 AU AU40547/99A patent/AU4054799A/en not_active Abandoned
- 1999-06-16 IL IL13863099A patent/IL138630A0/en unknown
- 1999-06-16 BR BR9911324-4A patent/BR9911324A/en not_active Application Discontinuation
- 1999-06-16 WO PCT/IB1999/001117 patent/WO1999065486A1/en not_active Application Discontinuation
- 1999-06-16 EA EA200001186A patent/EA200001186A1/en unknown
- 1999-06-16 ID IDW20002627A patent/ID27599A/en unknown
- 1999-06-16 CO CO99037622A patent/CO5070587A1/en unknown
- 1999-06-16 TN TNTNSN99124A patent/TNSN99124A1/en unknown
- 1999-06-16 EP EP99923802A patent/EP1087764A1/en not_active Withdrawn
- 1999-06-16 SK SK1891-2000A patent/SK18912000A3/en unknown
- 1999-06-16 HU HU0102505A patent/HUP0102505A3/en unknown
- 1999-06-16 KR KR1020007014186A patent/KR20010052852A/en not_active Ceased
- 1999-06-16 HR HR20000859A patent/HRP20000859A2/en not_active Application Discontinuation
- 1999-06-16 JP JP2000554366A patent/JP2002518326A/en active Pending
- 1999-06-16 PL PL99344981A patent/PL344981A1/en not_active Application Discontinuation
- 1999-06-16 CN CN99806237A patent/CN1301160A/en active Pending
- 1999-06-16 TR TR2000/03544T patent/TR200003544T2/en unknown
- 1999-06-16 MA MA25628A patent/MA26652A1/en unknown
- 1999-06-16 CA CA002335134A patent/CA2335134A1/en not_active Abandoned
- 1999-06-16 GT GT199900087A patent/GT199900087A/en unknown
-
2000
- 2000-10-20 OA OA1200000290A patent/OA11505A/en unknown
- 2000-10-27 IS IS5691A patent/IS5691A/en unknown
- 2000-12-11 BG BG105041A patent/BG105041A/en unknown
- 2000-12-12 NO NO20006312A patent/NO20006312L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| IS5691A (en) | 2000-10-27 |
| OA11505A (en) | 2004-05-07 |
| KR20010052852A (en) | 2001-06-25 |
| HUP0102505A2 (en) | 2001-11-28 |
| IL138630A0 (en) | 2001-10-31 |
| NO20006312D0 (en) | 2000-12-12 |
| EP1087764A1 (en) | 2001-04-04 |
| SK18912000A3 (en) | 2001-10-08 |
| HUP0102505A3 (en) | 2002-12-28 |
| ID27599A (en) | 2001-04-12 |
| CN1301160A (en) | 2001-06-27 |
| WO1999065486A1 (en) | 1999-12-23 |
| TR200003544T2 (en) | 2001-04-20 |
| TNSN99124A1 (en) | 2005-11-10 |
| HN1999000097A (en) | 1999-11-03 |
| BR9911324A (en) | 2001-04-03 |
| NO20006312L (en) | 2000-12-12 |
| BG105041A (en) | 2001-08-31 |
| AP9901582A0 (en) | 1999-06-30 |
| PL344981A1 (en) | 2001-11-19 |
| CA2335134A1 (en) | 1999-12-23 |
| EA200001186A1 (en) | 2001-06-25 |
| CO5070587A1 (en) | 2001-08-28 |
| ZA993975B (en) | 2000-12-15 |
| PE20000646A1 (en) | 2000-08-05 |
| PA8475901A1 (en) | 2000-05-24 |
| GT199900087A (en) | 2000-12-07 |
| JP2002518326A (en) | 2002-06-25 |
| HRP20000859A2 (en) | 2001-04-30 |
| AU4054799A (en) | 2000-01-05 |
| MA26652A1 (en) | 2004-12-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BG104668A (en) | Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors | |
| NO20021448L (en) | New thiazolo- (4,5-D) pyrimidine compounds | |
| AR035792A1 (en) | COMPOUNDS OF N- (4-QUINAZOLINIL) -N- (1H-INDAZOL-5-IL) AMINA, INHIBITOR OF RHO-KINASE, ITS USE FOR THE MANUFACTURE OF A MEDICINAL PRODUCT AND METHOD TO PREPARE IT | |
| IL145430A0 (en) | N-cyanomethyl amides, processes for the preparation thereof and pharmaceutical compositions containing the same | |
| FR2755967B1 (en) | PYRIDIN-2-YL-METHYLAMINE DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS MEDICAMENTS | |
| EE9900539A (en) | New compounds | |
| PT1263730E (en) | Amine derivatives for the treatment of apoptosis | |
| NO990663D0 (en) | Substituted pyrimidine derivatives and their pharmaceutical use | |
| NO302474B1 (en) | Saccharin derivatives, pharmaceutical composition and use thereof | |
| PA8529501A1 (en) | NEW TIADIAZOLS AND OXADIAZOLS AND THEIR USE AS INHIBITORS OF PHOSPHODIESTERASE -7. " | |
| NO993027D0 (en) | Pyrrolo [3,4-D] pyrimidinone derivatives and their use as drugs | |
| NO20050701L (en) | 4-pyrrolidino-phenyl-benzyl ether derivatives | |
| ECSP055701A (en) | NEW DERIVATIVES OF PYRIMIDINAMIDE AND THE USE OF THE SAME | |
| AR018869A1 (en) | PHARMACEUTICAL COMPOSITION, ITS USE FOR THE PREPARATION OF MEDICINES AND CASE THAT CONTAINS IT | |
| ATE440838T1 (en) | PHARMACEUTICALLY ACTIVE SULFONYLAMINOSIC ACID DERIVATIVES | |
| SE0101322D0 (en) | Novel compounds | |
| AR018868A1 (en) | PHARMACEUTICAL COMPOSITIONS FOR MUSCLE SCHEME FRAGILITY, USE FOR THE PREPARATION OF MEDICINES, CASE | |
| MXPA04005552A (en) | Vitamin d analogues. | |
| NO880406L (en) | 5- (3-ALKYL-5-TERT-BUTYL-4-HYDROXYPHENYL) -2-AMINO-6H-1,3,4-THIADIAZINES, PROCEDURES FOR THEIR PREPARATION AND MEDICINAL PRODUCTS CONTAINING THEM AND THEIR USE. | |
| NO995685L (en) | New glycosylated ginkgold derivatives, their use as medicaments and pharmaceutical compositions | |
| NO305082B1 (en) | 2- (4- (4-Azolbutyl) -1-piperazinyl) -5-hydroxy-pyrimidine derivatives, their preparation and use as drugs | |
| IL131216A0 (en) | Drugs inhibiting progress of pterygium and postoperative recurrence of the same | |
| ECSP993020A (en) | COMBINATION THERAPY FOR MUSCULOSKELETAL FRAGILITY | |
| ECSP993021A (en) | THERAPEUTIC COMBINATIONS FOR MUSCULOSKELETAL FRAGILITY | |
| DK47988A (en) | SUBSTITUTED 3-PHENYL-7H-THIAZOLOOE3,2-BAAOE1,2,4AATRIAZIN-7-ONER, THEIR PREPARATION AND APPLICATION AS MEDICINAL PRODUCTS, AND THE PRODUCTS USED INTERMEDIATELY |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |